Daniel Judge to Sarcomeres
This is a "connection" page, showing publications Daniel Judge has written about Sarcomeres.
Connection Strength
0.797
-
Judge DP. Why should cardiologists consider genetic testing for hypertrophic cardiomyopathy? JACC Heart Fail. 2015 Feb; 3(2):189-91.
Score: 0.553
-
Murray B, Hoorntje ET, Te Riele ASJM, Tichnell C, van der Heijden JF, Tandri H, van den Berg MP, Jongbloed JDH, Wilde AAM, Hauer RNW, Calkins H, Judge DP, James CA, van Tintelen JP, Dooijes D. Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC). J Cardiovasc Electrophysiol. 2018 07; 29(7):1004-1009.
Score: 0.177
-
Bales ND, Johnson NM, Judge DP, Murphy AM. Comprehensive Versus Targeted Genetic Testing in Children with Hypertrophic Cardiomyopathy. Pediatr Cardiol. 2016 Jun; 37(5):845-51.
Score: 0.038
-
Lakdawala NK, Funke BH, Baxter S, Cirino AL, Roberts AE, Judge DP, Johnson N, Mendelsohn NJ, Morel C, Care M, Chung WK, Jones C, Psychogios A, Duffy E, Rehm HL, White E, Seidman JG, Seidman CE, Ho CY. Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail. 2012 Apr; 18(4):296-303.
Score: 0.029